Showing results (1-10 of 1,366) with videos related to
Sort By:
Pageof 137
JAMA|October 17, 2002
Clinical use of bone densitometry: clinical applicationsDavid W Bates, Dennis M Black, Steven R CummingsJAMA|October 17, 2002
Clinical use of bone densitometry: scientific reviewSteven R Cummings, David Bates, Dennis M BlackJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 13, 2014
Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension studyRichard Eastell, Steven Boonen, Felicia Cosman, et al.The American Journal of Medicine|March 15, 2002
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugsSteven R Cummings, David B Karpf, Fran Harris, et al.JAMA Internal Medicine|May 7, 2014
Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX studyDouglas C Bauer, Ann Schwartz, Lisa Palermo, et al.The Journal of Clinical Endocrinology and Metabolism|September 13, 2014
Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?Felicia Cosman, Jane A Cauley, Richard Eastell, et al.JAMA Internal Medicine|August 12, 2014
Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acidTrisha F Hue, Steven R Cummings, Jane A Cauley, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 29, 2011
Effects of antiresorptive treatment on nonvertebral fracture outcomesDawn C Mackey, Dennis M Black, Douglas C Bauer, et al.Pageof 137